abnormal cardiovascular development_Kat7<tm1.2Avo>/Kat7<tm1.2Avo>

http://metadb.riken.jp/0002925IC57BL6Kat7tm12AvoKat7tm12AvoKat7tm12Avo

abnormal cardiovascular development_Kat7<tm1.2Avo>/Kat7<tm1.2Avo>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• K(lysine) acetyltransferase 7
  http://metadb.riken.jp/db/mgi_rdf/MGI:2182799

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Kat7<tm1.2Avo>/Kat7<tm1.2Avo>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Kat7<tm1.2Avo>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal cardiovascular development
  http://purl.obolibrary.org/obo/MP_0002925

文献

http://purl.org/net/cito/citesAsAuthority

• Andrew J. Kueh, et.al., HBO1 is required for H3K14 acetylation and normal transcriptional activity during embryonic development., Molecular and cellular biology, 2011, 31
  http://rdf.ncbi.nlm.nih.gov/pubmed/21149574